Abdelgalil AA,Alkahtani HM .2023 .Excipients and Related Methodology". Profiles of Drug Substances, : 135-166.
Bence AK,Anderson EB,Halepota MA .2005 .Phase I pharmacokinetic studies evaluating single and multiple doses of oral GW572016, a dual EGFR-ErbB2 inhibitor, in healthy subjects. Invest New Drugs, 23 : 39-49.
Calle MCA,Sandhu NP,Xia H .2018 .Two-dimensional speckle tracking echocardiography predicts early subclinical cardiotoxicity associated with anthracycline-trastuzumab chemotherapy in patients with breast cancer. BMC Cancer, 18(1) : 1037.
Chang VY,Wang JJ .2018 .Pharmacogenetics of chemotherapyinduced cardiotoxicity. Curr Oncol Rep, 20 : 52.
Chiba K,Kambayashi R,Onozato M .2022 .Imatinib induces diastolic dysfunction and ventricular early-repolarization delay in the halothane-anesthetized dogs: Class effects of tyrosine kinase inhibitors. J Pharmacol Sci, 150 : 154-62.
Chien KR .2006 .Herceptin and the heart-a molecular modifier of cardiac failure. N Engl J Med, 354 : 789-90.
Choi HD,Chang MJ .2017 .Cardiac toxicities of Lapatinib in patients with breast cancer and other HER2-positive cancers: a metaanalysis. Breast Cancer Res Treat, 166 : 927-936.
Dogan E,Yorgun H,Petekkaya I .2012 .Evaluation of cardiac safety of Lapatinib therapy for ErbB2-positive metastatic breast cancer: A single center experience. Med Oncol, 29 : 3232-3239.
Elhaieg A,Farag A,Elfadadny A .2023 .Effect of experimental periodontitis on cardiac functions: a comprehensive study using echocardiography, hemodynamic analysis, and histopathological evaluation in a rat model. Front Vet Sci, 1327484 : 1327484.
Farag A,Mandour AS,Kaneda M .2023 .Effect of trehalose on heart functions in rats model after myocardial infarction: assessment of novel intraventricular pressure and heart rate variability. Front Cardiovasc Med, 1182628 : 1182628.
Fonseca-Alves CE,Leis-Filho AF,Lacerda ZA .2024 .Lapatinib antitumor effect is associated with PI3K and MAPK pathway: An analysis in human and canine prostate cancer cells. PLoS One, 19 : e0297043.
Guerra M,Leite-Moreira AF .2018 .Relevance of intraventricular pressure gradients in left ventricular diastolic and systolic function: clinical implications. Rev Port Cir Cardiotorac Vasc, 25(1-2) : 19-26.
Hamabe L,Fukushima R,Kawamura K .2013 .Evaluation of changes in left ventricular myocardial function observed in canine myocardial dysfunction model using a two-dimensional tissue tracking technique. J Vet Sci, 14 : 355-62.
Hamabe L,Mandour AS,Shimada K .2021 .Role of two-dimensional speckle-tracking echocardiography in early detection of left ventricular dysfunction in dogs. Animals, 11 : 2361.
Hosono Y,Takahashi K,Shigemitsu S .2024 .Assessment of anthracycline-induced cardiotoxicity in childhood cancer survivors during long-term follow-up using strain analysis and intraventricular pressure gradient measurements. Heart Vessels, 39 : 105-116.
Iwano H,Kamimura D,Fox E .2015 .Altered spatial distribution of the diastolic left ventricular pressure difference in heart failure. J Am Soc Echocardiogr, 28 : 597-605.
Kang YJ .2001 .Molecular and cellular mechanisms of cardiotoxicity. Environ Health Perspect, 109 : 27-34.
Kerkelä R,Grazette L,Yacobi R .2006 .Cardiotoxicity of the cancer therapeutic agent imatinib mesylate. Nat Med, 10(8) : 908-16.
Klement GL,Goukassian D,Hlatky L .2012 .Cancer therapy targeting the HER2-PI3K pathway: potential impact on the heart. Front Pharmacol, 3 : 113.
Kobayashi M,Takahashi K,Yamada M .2017 .Assessment of early diastolic intraventricular pressure gradient in the left ventricle among patients with repaired tetralogy of Fallot. Heart Vessels, 32 : 1364-74.
Lamberti M,Giovane G,Garzillo EM .2014 .Animal models in studies of cardiotoxicity side effects from antiblastic drugs in patients and occupational exposed workers. Biomed Res Int, : 240642.
Lambertini M,Martel S,Campbell C .2019 .Pregnancies during and after trastuzumab and/or lapatinib in patients with human epidermal growth factor receptor 2-positive early breast cancer: Analysis from the NeoALTTO (BIG 1-06) and ALTTO (BIG 2-06) trials. Cancer, 125(2) : 307-16.
Maeda S,Sakai K,Kaji K .2022 .Lapatinib as first-line treatment for muscle-invasive urothelial carcinoma in dogs. Sci Rep, 12(4) : .
Mandour AS,Farag A,Helal MAY .2023 .Non-invasive assessment of the intraventricular pressure using novel color M-mode echocardiography in animal studies: Current status and future perspectives in veterinary medicine. Animals (Basel), 13(15) : 2452.
Matsuura K,Shiraishi K,Mandour AS .2021 .The utility of intraventricular pressure gradient for early detection of chemotherapy-induced subclinical cardiac dysfunction in dogs. Animals (Basel), 11 : 1122.
Matsuura K,Bach MBT,Takahashi K .2022 .Non-invasive assessment of left ventricular relaxation property using color Mmode-derived intraventricular pressure gradients in cats. J Vet Cardiol, 41 : 236-48.
McGregor P,Moura FA,Banchs J .2021 .Role of myocardial strain imaging in surveillance and management of cancer therapeuticsrelated cardiac dysfunction: a systematic review. Echocardiography, 38 : 314-28.
Morelli MB,Bongiovanni C,Da Pra S .2022 .Cardiotoxicity of anticancer drugs: Molecular mechanisms and strategies for cardioprotection. Front Cardiovasc Med, 9 : 847012.
Nagueh SF .2020 .Left ventricular diastolic function: Understanding pathophysiology, diagnosis, and prognosis with echocardiography. JACC Cardiovasc Imaging, 13 : 228-44.
Nguyen VA,Nguyen DT,Ong LTT .2023 .Early detection of reduced left ventricular systolic function by 2D speckle tracking echocardiography in patients with primary mitral regurgitation in a Vietnamese cohort. Glob Cardiol Sci Pract, : e202326.
Ohara T,Niebel CL,Stewart KC .2012 .Loss of adrenergic augmentation of diastolic intra-LV pressure difference in patients with diastolic dysfunction: Evaluation by color M-mode echocardiography. JACC Cardiovasc Imaging, 5 : 861-70.
Rawat PS,Jaiswal A,Khurana A .2021 .Doxorubicin-induced cardiotoxicity: An update on the molecular mechanism and novel therapeutic strategies for effective management. Biomed Pharmacother, 139 : 111708.
Shigemitsu S,Takahashi K,Yazaki K .2019 .New insight into the intraventricular pressure gradient as a sensitive indicator of diastolic cardiac dysfunction in patients with childhood cancer after anthracycline therapy. Heart Vessels, 34 : 992-1001.
Tanaka Y,Watanabe M,Saeki K .2020 .Evaluation of the proper dosage of lapatinib and its safety in dogs. Transl Regul Sci, 2 : 68-71.
Tassan-Mangina S,Codorean D,Metivier M .2006 .Tissue Doppler imaging and conventional echocardiography after anthracycline treatment in adults: Early and late alterations of left ventricular function during a prospective study. Eur J Echocardiogr, 7 : 141-46.
Wu Q,Bai B,Tian C .2022 .The molecular mechanisms of cardiotoxicity induced by HER2, VEGF, and tyrosine kinase inhibitors: An updated review. Cardiovasc Drugs Ther, 36(3) : 511-24.
Xie S,Sun Y,Zhao X .2024 .An update of the molecular mechanisms underlying anthracycline induced cardiotoxicity. Front Pharmacol, 15 : 1406247.
Yang Z,Wang W,Wang X .2021 .Cardiotoxicity of epidermal growth factor receptor 2-targeted drugs for breast cancer. Front Pharmacol, 12 : 741451.
Yotti R,Bermejo J,Antoranz JC .2005 .A noninvasive method for assessing impaired diastolic suction in patients with dilated cardiomyopathy. Circulation, 112 : 2921-29.
Yu TW,Yamamoto H,Morita S .2024 .Comparative pharmacokinetics of tyrosine kinase inhibitor, lapatinib, in dogs and cats following single oral administration. J Vet Med Sci, 86 : 317-21.